Real-world medication persistence among HIV-1 patients initiating integrase inhibitor-based antiretroviral therapy in Japan.

MLA

Wang, Xingzhi, et al. “Real-World Medication Persistence among HIV-1 Patients Initiating Integrase Inhibitor-Based Antiretroviral Therapy in Japan.” Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy, vol. 28, no. 11, Nov. 2022, pp. 1464–70. EBSCOhost, https://doi.org/10.1016/j.jiac.2022.07.005.

APA

Wang, X., Schmerold, L., & Naito, T. (2022). Real-world medication persistence among HIV-1 patients initiating integrase inhibitor-based antiretroviral therapy in Japan. Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy, 28(11), 1464–1470. https://doi.org/10.1016/j.jiac.2022.07.005

Chicago

Wang, Xingzhi, Luke Schmerold, and Toshio Naito. 2022. “Real-World Medication Persistence among HIV-1 Patients Initiating Integrase Inhibitor-Based Antiretroviral Therapy in Japan.” Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy 28 (11): 1464–70. doi:10.1016/j.jiac.2022.07.005.